Search
for
Sort by
Research 271–300 of 776
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- New Treatments for Hair Loss
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- The role of lymphocytes in the development and treatment of alopecia areata
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Alopecia Areata and Alopecia Areata Incognita
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- A Novel Hope for Alopecia Totalis Patients: Case Report
- 219 STAT5 activation in the dermal papilla is important for hair follicle growth phase induction, hair follicle regeneration and wound healing
- Ritlecitinib: First Approval
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Hair Follicle Reconstruction and Stem Cells
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Pharmacotherapy of alopecia areata
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Novedades terapéuticas en tricología
- Novel therapies for alopecia areata: The era of rational drug development
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison